AM, D., Y, S., BF, G., GL, M., D, S., J, J., . . . VS, B. (2026). Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39). JCO oncology practice, OP2600015. https://doi.org/10.1200/OP-26-00015
Chicago Style (17th ed.) CitationAM, Deal, et al. "Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39)." JCO Oncology Practice 2026: OP2600015. https://doi.org/10.1200/OP-26-00015.
MLA (9th ed.) CitationAM, Deal, et al. "Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39)." JCO Oncology Practice, 2026, p. OP2600015, https://doi.org/10.1200/OP-26-00015.
Warning: These citations may not always be 100% accurate.